As the CGM market continues to mature it’s time to start looking at different metrics to measure success. Right now, the CGM market is following the early days of the insulin pump market. It’s all about how many patients a company can get onto their system. Yet as the pump market matured the story changed and it became not just how many new patients were added but also how many patients stayed on the system.
Thanks to Abbott every CGM company now talks about how many patients are using their system, patient growth is everything. However new patient . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.